In this edition:

Feature

Funding (* New Opportunities)

NIH Funding Opportunities Specific to COVID-19

This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).

Notice of Intent to Publish ROA for NIH Post-Acute Sequelae of SARS-CoV-2 Infection Initiative

This Notice is to alert the community that NIH plans to publish two additional ROAs in support of the PASC Initiative, one on PASC Data Repositories and one on a Mobile Health Platform. The solicited research will improve understanding of and develop strategies to prevent and treat post-acute manifestations of SARS-CoV-2 infection across the lifespan. This Notice is being provided for informational purposes to allow potential applicants additional time to develop responsive applications.

NOSI: Support for Existing Data Repositories to Align with FAIR and TRUST Principles and Evaluate Usage, Utility, and Impact – Due May 20

The goal of this NOSI is to strengthen NIH-funded biomedical data repositories to better enable data discoverability, interoperability, and reuse by aligning with the FAIR and TRUST principles and using metrics to measure their effectiveness. This NOSI provides an opportunity for existing repositories to increase FAIR-ness and TRUST-worthiness to improve their usage, utility, and impact throughout the data resource lifecycle.

NOSI: Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional) – Due May 24

This NOSI provides an expedited funding mechanism to support Phase II of the RADx-UP initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADx-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines.

PCORI Building Capacity for PCOR/CER in Intellectual and Developmental Disabilities – Due May 24

This special funding opportunity will support projects that enable organizations and communities to build their capacity and skills to participate across all phases of the PCOR/CER process on topics that address health outcomes related to intellectual and developmental disabilities. Projects will also provide an understanding of the impact of stakeholder engagement strategies within different settings and stakeholder groups focused on this special area of interest.

Chan Zuckerberg Initiative Ancestry Networks for the Human Cell Atlas – Due May 25

This funding opportunity supports the continued growth of the HCA, with the aim of filling potential gaps in the first draft of the healthy reference atlas around ancestral groups that have been historically understudied in the biomedical sciences. This RFA seeks to attract a new set of grantees primed to answer questions related to commonalities and potential differences in ancestry at the cellular level, as well as grantees with experience in community engagement and building diverse cohorts, and/or access to ancestrally diverse donors and tissue.

Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) – LOI Due May 28

The purpose of this FOA is to promote partnerships between intramural investigators at the NCATS 3-D Bioprinting Laboratory and extramural researchers to jointly develop and demonstrate the use of 3-D biofabricated tissues for disease modeling and drug screening.

SOM I3 (Imagine, Innovate and Impact) Venture Award – Due June 7

Emory SOM is soliciting innovative research proposals to catalyze promising early-stage concepts with commercial potential that do not yet qualify for funding from external sources. The I3 Venture Research Awards aim to cultivate inventors, innovators, and entrepreneurs driven to solve medicine’s challenges and create patient impact.

Robert Wood Johnson Foundation Systems for Action Systems and Services Research to Build a Culture of Health – Due June 9

Systems for Action is a signature research program of the Robert Wood Johnson Foundation (RWJF) that builds a Culture of Health by rigorously testing new ways of connecting the nation’s fragmented medical, social, and public health systems. RWJF will fund up to 4 awards of up to $500,000 each.

HEAL Initiative: NOSI: Limited Competition to Support Mentorship of Junior Investigators – Due June 12

This NOSI provides an opportunity for researchers funded by the Helping to End Addiction Long-Term (HEAL) initiative to devote more time to patient-oriented research and mentoring. For the purposes of the K24 award, patient-oriented research is defined as research conducted with human subjects for which an investigator (or colleague) directly interacts with human subjects. This area of research includes therapeutic interventions and clinical trials.

Bridges to the Doctorate Research Training Program (T32) – Emory Internal Due June 15

The goal of the Bridges to the Doctorate Research Training Program is to develop a diverse pool of scientists earning a Ph.D. who have the skills to successfully transition into careers in the biomedical research workforce. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. For any questions, please contact Holly Sommers (hsomme2@emory.edu).

Regenerative Engineering and Medicine Center Call for Therapeutic Delivery Innovation Initiative Collaborative Grant Program – Due June 25

This funding mechanism is intended to stimulate new, collaborative research in therapeutic delivery among Georgia Tech, Emory University, and UGA investigators. The collaborative grant team must have a minimum of two investigators and must have an equal partnership of faculty from two of the participating institutions with budgets split between the universities as equally as possible.

Pfizer Centers for Therapeutic Innovation – Due June 28

Pfizer’s CTI partnering model focuses on accessing cutting-edge science and innovative discoveries aligned with Pfizer’s current core research areas of Oncology, Inflammation & Immunology, Rare Diseases, and Internal Medicine. Please reach out to Kevin Lei for any questions and to apply.

* Robert Wood Johnson Foundation Leadership and Management of the RWJF Culture of Health Prize – Due June 30

RWJF seeks an organization to lead and manage the national RWJF Culture of Health Prize program. This request for qualifications (RFQ) provides background on the program and outlines qualifications and responsibilities for the next lead organization. As part of this RFQ, RWJF asks the applicant to provide an estimated $4 million to $6 million budget over 27 months.

Damon Runyon Cancer Research Foundation Rachleff Innovation Award – Due July 1

This award funds extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.

Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) – Due July 7

This Phase II RADx-UP FOA is designed to expand research to understand and address the social, ethical, and behavioral implications of COVID-19 testing interventions among underserved and vulnerable populations.

Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) – Due July 8

This FOA uses an emergency U01 mechanism to support Phase II of RADx-UP initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADx-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines.

Nutrition Obesity Research Centers (P30 Clinical Trial Optional) – Internal Due August 2

This FOA invites applications from institutions/organizations that propose to establish core centers that are part of an integrated and existing program of nutrition and/or obesity research. The Nutrition Obesity Research Centers program is designed to support and enhance the national research effort in nutrition and obesity.

Education

Free Online Trainings for Clinical Research Professionals

Georgia CTSA and the University of Southern California Clinical and Translational Science Institute (SC CTSI) have created a new Online Course Catalog with free course and program offerings available to clinical research professionals. Participants earn a certificate or badge with contact hours (continuing education – CE) from an accredited provider upon completion of a course or a program (series of courses). Contact hours can be used to meet requirements for CRP certification renewal. The newest program, “Regulatory Aspects of Clinical Trial Design”, is now available online. Select a course/program that interests you and click on the blue “Enroll” button.

Research Resources

N3C - COVID-19 Analytics Platform

Researchers studying COVID-19 are able to access an innovative analytics platform that contains clinical data from the electronic health records of people who were tested for the novel coronavirus or who have had related symptoms. Part of the NCATS National COVID Cohort Collaborative (N3C) Data Enclave, the centralized and secure data platform features powerful analytics capabilities for online discovery, visualization and collaboration.

Georgia CTSA COVID-19 Biorepository

The Georgia CTSA Clinical Research Center at Emory has established a COVID-19 Biorepository that includes residual nasopharyngeal (NP) swab samples from over 1,700 patients known to be COVID-19 positive and negative. Our goal is to provide de-identified samples to investigators validating or developing diagnostics and therapeutics in an effort to improve the understanding of the effects, response, and mechanism of the SARS-CoV-2 virus and its variants.

Georgia CTSA Ethical Dilemma of the Week

NEW Dilemma - Drug Trials: Ethical Conduction of an International Pediatric Trial (PDF)

Innovation & Translation

Bench2Market Talks: Go to Market Strategy – May 12

This interactive workshop at 11:30 AM will guide you through the process of setting commercialization milestones and determining your most critical next steps for a 'killer' experiment. Speaker, Brian Walsh, is an industry leader with more than 30 years of experience successfully taking technologies from ideas to the market. For more details on the series, view the full schedule .

Global Center for Medical Innovation (GCMI) Baby SharQ Tank – Submit by June 15

Looking for guidance and funding to help your early stage medical device novel innovation get to a ‘minimally viable prototype’? Baby SharQ Tank wants to help you. A team of pediatric physicians and surgeons along with a skilled engineering team focused on medtech device design and development, are collaborating with GCMI to help pediatric proceduralists and entrepreneurs who may have a device idea or a solution for an unmet clinical need in pediatric healthcare with potential to make it a viable business opportunity. The winning team will receive guidance and in-kind funding from generous sponsors to take the idea to the next level and see if it can be made a reality for future funding opportunities.

Community

Participants Needed for COVID-19 Vaccine and Therapeutic Trials

Adults 18 and older, from all races and ethnicities, are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials.

Events

COVID Force Seminar – TODAY

Join us via Zoom at 12:00 PM – 1:00 PM to learn more about “Multisystem Inflammatory Syndrome in Children. What do we know so far?” with Assistant Professor Keiko M. Tarquinio, M.D. FAAP and “SARS-CoV-2 Serology in Children with COVID-19 and MIS-C” with Assistant Professor Christina A. Rostad, MD.

7th Annual Health Services Research Day – May 5

Health Services Research Day is going virtual! Join us for this symposium and networking opportunity where researchers across Georgia will learn about ongoing quality, effectiveness, and value-based research activities.

Nanotechnology in Vaccine Delivery – May 5, 12, 19, 26

Spring 2021 NanoFANS program will offer a weekly webinar from 11:00 AM - 12:00 PM via Zoom. The focus of this event will be “Nanotechnology in Vaccine Delivery.”

CIAG Seminar – May 6

Join us via Zoom from 4:00 PM – 5:00 PM to learn more about “Molecular Requirements for the Generation of Functional B Cells in Humans” with Stuart Tangye, PhD

K-Club – May 10

Join us via Zoom from 12:00 PM – 1:00 PM to learn more about “Perfecting and Integrating The Career Development Components of a K Grant Application” with Jaime S. Rubin, PhD.

Regenerative Engineering and Medicine Center's (REM) Annual Retreat – May 10

Join us from 10:30 – 12:30 via Zoom for the annual retreat hosted by UGA, Georgia Tech, and Emory with keynote from Dr. Ted Ross, “Universal Vaccines for Flu and COVID-19.” Advances in the delivery of molecular and biological therapeutics that will enhance the body’s ability to heal itself will be discussed, along with opportunities to meet with PIs who will apply to the “Therapeutic Delivery Innovation Initiative” collaborative grant RFA on this topic. Register now to collaborate with PIs via SLACK one month prior to the event.

Emory DOM Health Equity Day – May 11

Emory Department of Medicine's inaugural Health Equity Day via Zoom from 9:00 AM - 2:00 PM includes poster presentations on clinical quality, research, education, professional development, advocacy, and outreach; a case competition; storytelling pre-event; and keynote address from Lisa Cooper, MD, MPH, Professor of Medicine at Johns Hopkins University and Director of the institution’s Center for Health Equity.

Blue Sky Group: COVID -19 Vaccine Hesitancy – May 12

Join researchers and clinicians from across the Georgia CTSA via Zoom from 4:30 – 6:00 PM. Blue Sky Groups are unstructured meetings that provide a unique opportunity for attendees to drive the agenda and catalyze future collaborations and research opportunities. Share your experience, learn from others, enjoy opportunities for interdisciplinary networking and find potential collaborators!

Practical and Fun Look at Low Cost CEU Management – May 13

Southeastern Pediatric Research Conference – June 11

Please join us for the 10th anniversary of our annual event to highlight the scope of pediatric research being conducted across the southeast and specifically at Emory, Children’s, Georgia Tech, and MSM. Get ready for an exciting day of presentations, poster sessions, networking and knowledge-sharing, plus a special 10th anniversary reception! Learn more and register .